Long-term efficacy assessment of current treatment options for epistaxis in HHT.

Bevacizumab Epistaxis Hereditary hemorrhagic telangiectasia Laser photocoagulation Rendu-osler Rhinology

Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 25 10 2020
accepted: 09 02 2021
pubmed: 5 3 2021
medline: 6 10 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder that presents with recurrent, intractable epistaxis. The aim of this study was to retrospectively analyze the efficacy of various treatment options for epistaxis in patients with HHT, over a period of 18 years, and to correlate these findings with available evidence in the literature. Records of patients with HHT, treated for epistaxis between 2000 and 2018 were analyzed. Treatment procedures carried out and their efficacy were extracted and analyzed. Forty-three records were evaluated. All patients were given nasal humidifying ointments, 93% required acute treatment with bipolar electrocautery, and 60% underwent atraumatic nasal packing. Recurrent cases were treated medically with tranexamic acid (26%), oestrogen (19%), and bevacizumab (2%). Laser photocoagulation was done in selected cases (40%) and if unsuccessful, septal dermoplasty was performed (2.3%). Endovascular embolization was reserved for life-threatening emergencies (7%). Epistaxis in HHT is not curable, but can be managed by employing a comprehensive stepwise approach. An algorithm for effective and comprehensive management has been presented.

Identifiants

pubmed: 33661356
doi: 10.1007/s00405-021-06701-z
pii: 10.1007/s00405-021-06701-z
pmc: PMC8486717
doi:

Substances chimiques

Bevacizumab 2S9ZZM9Q9V

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4321-4328

Informations de copyright

© 2021. The Author(s).

Références

J Laryngol Otol. 2011 Nov;125(11):1176-80
pubmed: 21846415
Am J Med Genet. 2000 Mar 6;91(1):66-7
pubmed: 10751092
J Med Genet. 2011 Feb;48(2):73-87
pubmed: 19553198
Laryngoscope. 1982 Mar;92(3):314-20
pubmed: 7040867
Radiol Med. 1995 Jun;89(6):861-4
pubmed: 7644743
JAMA. 2016 Sep 6;316(9):943-51
pubmed: 27599329
Rhinology. 2018 Mar 1;56(1):3-10
pubmed: 29166422
Case Rep Med. 2010;2010:321835
pubmed: 20368796
Eur Arch Otorhinolaryngol. 2011 Dec;268(12):1765-70
pubmed: 21706320
Laryngoscope. 2018 Oct;128(10):2237-2244
pubmed: 29469958
Laryngoscope. 2009 Feb;119(2):284-8
pubmed: 19160429
Auris Nasus Larynx. 2016 Aug;43(4):429-32
pubmed: 26739947
J Laryngol Otol. 2002 Jun;116(6):455-6
pubmed: 12385360
Clin Otolaryngol. 2017 Aug;42(4):911-917
pubmed: 28032956
Otolaryngol Head Neck Surg. 2017 Aug;157(2):217-221
pubmed: 28418273
Am J Rhinol. 2007 May-Jun;21(3):312-5
pubmed: 17621815
Lasers Surg Med. 2020 Apr;52(4):293-300
pubmed: 31441079
Laryngoscope. 2004 Apr;114(4):705-9
pubmed: 15064628
Am J Med Genet A. 2012 Jun;158A(6):1269-78
pubmed: 22529055
Laryngoscope. 2019 Oct;129(10):2216-2223
pubmed: 30908653
J Intern Med. 1999 Jan;245(1):31-9
pubmed: 10095814
Otolaryngol Head Neck Surg. 2019 Jan;160(1):22-35
pubmed: 30200816
Laryngoscope. 2013 Apr;123(4):820-2
pubmed: 23401038
Laryngoscope. 2018 Oct;128(10):2234-2236
pubmed: 29451965
Turk J Haematol. 2018 Jun 8;36(1):43-47
pubmed: 29880465
Int Forum Allergy Rhinol. 2015 May;5(5):435-40
pubmed: 25643928
J Otolaryngol Head Neck Surg. 2017 Oct 4;46(1):58
pubmed: 28978360
Laryngoscope Investig Otolaryngol. 2018 Apr 19;3(3):178-181
pubmed: 30062132
Am J Rhinol Allergy. 2018 Jul;32(4):258-268
pubmed: 29745243
Acta Radiol. 2011 Oct 1;52(8):846-9
pubmed: 21816895
Am J Rhinol. 2008 Mar-Apr;22(2):182-7
pubmed: 18416977
Int Forum Allergy Rhinol. 2014 Aug;4(8):640-5
pubmed: 24719397
Rhinology. 2019 Aug 1;57(4):242-251
pubmed: 30907391
Thromb Res. 2014 Sep;134(3):565-71
pubmed: 25005464
Acta Med Scand. 1981;209(5):393-6
pubmed: 7018182

Auteurs

Cilgia Dür (C)

Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, University of Bern, Bern, Switzerland. cilgia.duer@insel.ch.

L Anschuetz (L)

Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, University of Bern, Bern, Switzerland.

S Negoias (S)

Department of ENT, Head and Neck Surgery, University of Basel, Basel, Switzerland.

O C Bulut (OC)

Department of ENT, University Heidelberg, 69120, Heidelberg, Germany.

A Angelillo-Scherrer (A)

Department of Hematology, Inselspital, University of Bern, Bern, Switzerland.

M Caversaccio (M)

Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH